Migræne kliniske forsøg i Californien
18 studier for Migræne søger deltagere på steder i Californien.
Byer i Californien
- Concord8 studier
- San Diego6 studier
- Fresno5 studier
- Los Angeles4 studier
- Pomona4 studier
- Long Beach4 studier
- Anaheim4 studier
- Oceanside3 studier
Officiel studietekst (engelsk)
Study of EVO756 in Adults With Migraine
- Buena Park Research Center, Buena Park
- Neuro Pain Research Center, Fresno
- CA Medical Clinic for Headache, Los Angeles
- og 1 flere
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Advanced Investigative Medicine, Inc., Hawthorne
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 28. sep. 2026 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- John Muir Physician Network Clin. Research Center, Walnut Creek
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT06735833Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Advanced Research Center, Inc., Anaheim
- Neuro-Pain Research Center, Fresno
- Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla
- og 4 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Advanced Research Center, Inc., Anaheim
- Adult & Child Neurology Medical Associates, Costa Mesa
- Memorial Health Services, Fountain Valley
- og 9 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Advanced Research Center /ID# 270257, Anaheim
- Neuro Pain Research Center /ID# 271048, Fresno
- Accellacare - Long Beach /ID# 270398, Long Beach
- og 3 flere
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of California San Francisco, San Francisco
Rekrutterer
Alder 10 til 17 · Alle køn · Opdateret 21. sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Keck School of Medicine of USC, Los Angeles
- Clinical Research Institute, Los Angeles
- Desert Physicians Medical Group, Palm Springs
- og 1 flere
RekruttererFase 4
Alder 18 til 70 · Alle køn · Opdateret 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Advanced Research Center /ID# 227962, Anaheim
- Neuro Pain Research Center /ID# 227966, Fresno
- Imax Clinical Trials /ID# 281436, La Palma
- og 7 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Sunwise Clinical Research, Llc, Walnut Creek
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 2. sep. 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Axiom Research, LLC, Colton
- ProScience Research Group, Culver City
- Leading Edge Research LA, LLC, Encino
- og 15 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924Emgality for Migraine in Breastmilk
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 til 45 · Kvinder · Opdateret 11. aug. 2026 · NCT06085144Treatment of Meniere's Disease With Migraine Medications
- University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange
RekruttererFase 4
Alder 25 til 85 · Alle køn · Opdateret 22. jun. 2026 · NCT05582837A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- The Neurology Center of Southern California - Carlsbad Office, La Jolla
- Clinical Research Institute, LCC, Los Angeles
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 19. maj 2026 · NCT06602479Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
- Peter H Hwang, Stanford
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 27. apr. 2026 · NCT04930887Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Neurology and Pain Specialty Center /ID# 278508, Aliso Viejo
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 10. feb. 2026 · NCT07310290Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
- Stanford University School of Medicine, Stanford
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 23. jul. 2025 · NCT03231241Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #15, La Jolla
RekruttererFase 4
Alder 6 til 11 · Alle køn · Opdateret 27. jan. 2025 · NCT04748601Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.